Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Patient sues Abbott after early heart valve replacement
The patient's Trifecta GT heart valve had to be replaced after just six years, an experience he says resulted in "permanent injuries." Abbott pulled the devices off the U.S. market in 2023 due to a known risk of structural valve deterioration.
FDA clears new AI-enabled coronary plaque analysis software
Circle Cardiovascular Imaging, a Canadian medtech company, received the key approval for its cvi42 | Plaque platform.
Evoque TTVR system linked to favorable outcomes in new real-world analysis
Researchers tracked data from more than 1,000 real-world patients, focusing on 30-day safety and efficacy outcomes. The group shared its findings at TCT 2025 in San Francisco.
First-in-human data highlight IVL’s potential to treat more challenging lesions
Shockwave Medical and FastWave Medical have shared new first-in-human data on their advanced IVL offerings. Both companies are focused on addressing difficult-to-cross lesions that often cause problems for cardiologists.
Medicare now covers renal denervation for patients with uncontrolled hypertension
This decision expands access to renal denervation to many more patients throughout the United States. Recor Medical and Medtronic both gained FDA approval for their RDN systems in 2023, and other vendors are actively developing their own treatment options.

Video with former ACC president Kim Williams, MD, discusses a heart screening outreach program he created in low-income Louisville neighborhoods.

Successful outreach program brings heart screenings to underserved communities

Former ACC president Kim Allan Williams Sr., MD, shared his experience bringing helpful heart screenings to low-income neighborhoods. "You've got to be willing to go out and find where the patients are," he said.

Artificial heart developer gains key approval as money troubles continue

Carmat is working to overcome financial struggles that forced it to suspend new device implants through the end of August. Even with its future in limbo, the company remains focused on moving forward.

FDA announces Class I recall due to heart pump controller issue

The FDA previously shared an early alert about this issue, but it was still reviewing the situation at the time. The new recall covers a total of more than 11,000 devices.

cardiologist patient heart compensation starting salary 2022 interventional cardiologist

The best heart hospitals in the United States

U.S. News & World Report has released its annual ranking of the top U.S. hospitals for cardiology, heart surgery and vascular surgery. Did your facility make the cut this year?

ICD patients may experience fear, anxiety or depression due to their devices

Some patients feel anxiety due to the risk of being shocked. Others have device recalls and/or cybersecurity threats on their mind.

Cardiac surgeon John Puskas, MD, Emory University, says CCTA will make invasive angiography obsolete very soon.

CCTA could make invasive angiography a thing of the past

John Puskas, MD, thinks coronary CT angiography is on its way to completely transforming patient care.

Stereotaxis MAGIC SWEEP electrophysiology catheter

FDA clears first robotically guided EP mapping catheter for ablation

Stereotaxis has received FDA clearance for the first mapping catheter of its kind. The company emphasized that this is just the first of many robotically navigated devices it is working to bring to the U.S. market.

The pandemic accelerated brain aging, even in those who never contracted COVID

The new data is prompting questions about how stress, isolation and the disruption of normal routines affect the brain on a physiological level.

Clinical

Patient sues Abbott after early heart valve replacement

FDA clears new AI-enabled coronary plaque analysis software

Evoque TTVR system linked to favorable outcomes in new real-world analysis

First-in-human data highlight IVL’s potential to treat more challenging lesions

Medicare now covers renal denervation for patients with uncontrolled hypertension